Rabies Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 60 pages | ID: R82647C6D4F6EN
VPAResearch

Abstracts

Rabies Drug pipeline report- 2020 is an annual R&D review of Rabies pipeline candidates. The report presents the current status of all major Rabies therapeutic compounds. Detailed insights into Rabies pipeline development, current status, companies, drug profiles and Rabies preclinical and clinical trials are included.

2020 Rabies Pipeline Market Insights
Rabies disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Rabies therapies, pipeline by phase and others are included.

Rabies pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Rabies Therapeutic Drug candidates
Both active and inactive Rabies pipeline drug candidates are included in the report

Rabies Clinical Trials and preclinical Studies
Rabies In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Rabies pipeline market developments
Rabies Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Rabies pipeline companies in active development
The report analyzes Rabies pipeline of the below companies-

Cadila Healthcare Ltd, Celltrion Inc, Changchun Institute of Biological Products, CPL Biologicals Pvt Ltd, Curevac AG, Exxell BIO Inc, GlaxoSmithKline Plc, Indian Immunologicals Ltd, Mid-Atlantic BioTherapeutics Inc, Molecular Targeting Technologies Inc, NanoViricides Inc, Prosetta Biosciences Inc, Sanofi Pasteur SA, Synermore Biologics Co Ltd, Vir Biotechnology Inc, Yisheng Biopharma Co Ltd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
16 Companies investing in Rabies pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Rabies pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. RABIES PIPELINE MARKET INSIGHTS, 2020

1.1 Rabies Disease Overview
1.2 Rabies Drug Pipeline Snapshot, 2020
  1.2.1 Rabies Pipeline Drugs by Phase
  1.2.2 Rabies Pipeline Drugs by Company
  1.2.3 Rabies Pipeline Drugs by Mechanism of Action
  1.2.4 Rabies Pipeline Drugs by Route of Administration

2. RABIES COMPANY WISE PIPELINE DETAILS

Cadila Healthcare Ltd Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Celltrion Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Changchun Institute of Biological Products Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
CPL Biologicals Pvt Ltd Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Curevac AG Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Exxell BIO Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Indian Immunologicals Ltd Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Mid-Atlantic BioTherapeutics Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Molecular Targeting Technologies Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Prosetta Biosciences Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pasteur SA Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Synermore Biologics Co Ltd Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vir Biotechnology Inc Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details
Yisheng Biopharma Co Ltd Rabies Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. RABIES DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. RABIES PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts